NCT05778968View on ClinicalTrials.gov

Etco2 Levels on the End-tidal Concentration of Sevoflurane

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

July 29, 2024

Conditions
End-tidal SevofluraneEnd-tidal Carbon DioxideMinimum Alveolar Concentration
Interventions
PROCEDURE

low etco2

Etco2 levels will be adjusted at levels ranging between 25 mm Hg and 30 mm Hg

PROCEDURE

normal etco2

Etco2 levels will be adjusted at levels ranging between 31 mm Hg and 40 mm Hg

PROCEDURE

high etco2

Etco2 levels will be adjusted at levels ranging between 41 mm Hg and 45 mm Hg

Trial Locations (1)

31111

tarek Abdelhay Mostafa, Tanta

All Listed Sponsors
lead

Tanta University

OTHER